Laura Cabiedes-Miragaya

Dr. Laura Cabiedes-Miragaya

Senior lecturer of Applied Economics at the University of Oviedo (Spain)

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Laura Cabiedes-MiragayaLaura Cabiedes-Miragaya
Laura Cabiedes-Miragaya
CDCecilia Diaz-Mendez
Cecilia Diaz-Mendez
IGIsabel García-Espejo
Isabel García-Espejo
The so-called Mediterranean diet is not simply a collection of foodstuffs but an expression of the culture of the countries of the south of Europe, declared Intangible Cultural Heritage by UNESCO. Despite the link between food and culture, little has been studied about how diet contributes to the well-being of the population. This article aims to analyze the association between subjective well-being and the eating habits of the Spanish population in order to gain a better understanding of the subjective well-being that food culture produces. For this study, we used a representative sample of the Spanish adult population from a survey by the Sociological Research Center (CIS 2017). Three indicators of subjective well-being were used: perceived health, life satisfaction, and feeling of happiness. The independent variables relating to eating habits considered in the analysis were, among others, how often meat, fish, vegetables, fruit, and sweets were consumed; how the food was prepared; how often meals were eaten out at restaurants or cafés and how often they were eaten with family or friends. Other independent variables related to lifestyle habits were also included in the analysis, in particular, physical exercise and body mass index. We used ordinal logistic regressions and multiple linear regression models. Our findings coincide in large measure with those obtained in earlier studies where perceived health and income play a key role in evaluating subjective well-being. In turn, several variables related to lifestyle habits, such as consuming sweets and fruits, social interaction around meals, exercising, and body mass index, were also associated with subjective well-being.

1 December 2017 in Appetite
Verified
Journal Article
Open access
Laura Cabiedes-MiragayaLaura Cabiedes-Miragaya
Laura Cabiedes-Miragaya
The objective of this article is to analyse the structure of the Spanish eating-out sector from an economic point of view, and more specifically, from the supply perspective. This aspect has been studied less than the demand side, almost certainly due to the gaps which exist in available official statistics in Spain, and which have been filled basically with consumer surveys. For this reason, focus is also placed on the economic relevance of the sector and attention is drawn to the serious shortcomings regarding official statistics in this domain, in contrast to the priority that hotel industry statistics have traditionally received in Spain. Based on official statistics, a descriptive analysis was carried out, focused mainly, though not exclusively, on diverse structural aspects of the sector. Special emphasis was placed on issues such as business demography (for instance, number and types of enterprises, survival rates, size distribution, and age structure), market concentration and structure of costs. Among other conclusions, the analysis allowed us to conclude that: part of the sector is more concentrated than it may at first appear to be; the dual structure of the sector described by the literature in relation to other countries is also present in the Spanish case; and the impact of ICTs (Information and Communication Technologies) on the sector are, and will foreseeably continue to be, particularly relevant. The main conclusion of this study refers to the fact that consumers have gained prominence in their contribution to shaping the structure of the sector.

16 October 2018 in Papers. Revista de Sociologia
Verified
Journal Article
Open access
PDF file
Laura Cabiedes-MiragayaLaura Cabiedes-Miragaya
Laura Cabiedes-Miragaya
LLUÍS Miret-PastorLLUÍS Miret-Pastor
LLUÍS Miret-Pastor
La restauración es una parte fundamental del turismo. Sin embargo, existen pocos trabajos cuantitativos ya que es un sector difícil de estudiar. El objetivo de este artículo es estudiar las posibilidades de análisis del sector de la restauración en España apoyándose en las principales fuentes estadísticas. Con este fin, se describen y comparan las bases de datos disponibles para analizar el sector tanto desde la perspectiva de la demanda como de la oferta. El artículo concluye con algunas sugerencias para determinar qué estadísticas conviene utilizar y qué medidas sería deseable que fuesen adoptadas para mejorar la información estadística.

10 February 2022 in Journal of Medical Ethics
Verified
Journal Article
Open access
PDF file
Laura Cabiedes-MiragayaLaura Cabiedes-Miragaya
Laura Cabiedes-Miragaya
IGInés Galende-Domínguez
Inés Galende-Domínguez
Currently, millions of minors are being inoculated against SARS-CoV-2 in many countries in the world. Ethical concerns about clinical research involving children have barely been addressed in the literature, despite the fact that the paediatric population is particularly vulnerable within this context. Children should be included in the research plans for COVID-19 vaccines. Nevertheless, it is necessary to critically assess to what extent clinical trials are being conducted according to methodological and ethical criteria that allow us to conclude that the results are valid and, in consequence, how far the vaccination plans for children are scientifically justified.The principal aim of this article is to analyse critically the process of clinical research on COVID-19 vaccines involving children, highlighting the ethical concerns that arise, including the need to stratify the results from older adolescents separately for analysis before proceeding, if further research is warranted, in descending age order. The development of COVID-19 vaccines is examined, with a special look at the participation of children throughout their clinical development, including a review of the clinical trials registered in three international databases. We also offer some additional considerations about the inclusion of minors in vaccination plans. Finally, we conclude with some recommendations, with particular emphasis on the following ethical duties: research in children should be carried out only once the relevant research in adults has previously been conducted; issues that concern children’s needs and rights should be specifically addressed; and, therefore, the highest standards of ethical and scientific quality should be met.

28 February 2013 in Gaceta Sanitaria
Verified
Journal Article
Open access
Laura Cabiedes-MiragayaLaura Cabiedes-Miragaya
Laura Cabiedes-Miragaya
ResumenEl objetivo de este artículo es analizar cómo las innovaciones farmacológicas para el cáncer son objeto de frecuentes excepciones al proceso habitual de evaluación económica de tecnologías, así como su impacto en la regulación de estos procesos y de los contratos de riesgo compartido, particularmente utilizados en este ámbito. Con este fin se seleccionaron dos agentes representativos de los primeros tratamientos dirigidos, el trastuzumab y el imatinib, y se procedió a la revisión de algunas experiencias internacionales (Australia, Gales e Inglaterra, pioneros en la aplicación de estudios de evaluación económica de tecnologías), en especial, aunque no exclusivamente, centradas en estos dos casos. De la revisión de las experiencias se desprende que, aparte de la eficiencia, otros criterios pueden resultar particularmente relevantes en los procesos de evaluación de este tipo de innovaciones. En Inglaterra y Gales (donde, a diferencia de Australia, no se aplica la «regla de rescate»), los controvertidos procesos de toma de decisiones han llevado a la regulación de nuevos enfoques en la evaluación de estos tratamientos. Asimismo, el solapamiento de los contratos de riesgo compartido o su aplicación secuencial han llamado la atención sobre posibles problemas de inconsistencia en la toma de decisiones y de equidad en el acceso, resultando en su regulación para el conjunto del sistema. Se concluye con una referencia específica al caso español, centrada en el riesgo de profundizar en la aplicación de fórmulas micro (como los contratos de riesgo compartido) frente a macro, y se sugiere una estrategia de actuación apoyada en el recientemente aprobado Real Decreto-ley 9/2011.AbstractGiven that new oncology drugs are frequently involved in departures from the normal technology appraisal processes, the main objective of this article is to analyze these decision-making processes, as well as their impact on the regulation of new approaches to selecting novel drugs and the regulatory steps to deal with risk-sharing arrangements. This analysis was carried out by selecting two drugs, trastuzumab and imatinib, both agents being representive examples of the innovative targeted therapies introduced in the last decade, and by reviewing some international experiences (particularly those of Australia, England, and Wales, pioneers in the application of technology appraisals), centered mainly – but not exclusively – on these two drugs. The review of these experiences indicated that other concerns apart from efficiency are especially important in the evaluation of this type of innovations. In England and Wales (where, in contrast to Australia, the “rule of rescue” has not been adopted) the controversial decision-making processes have resulted in new approaches to the appraisal of end-of-life treatments. Moreover, overlapping or sequential risk-sharing arrangements have led to regulatory steps, paying attention to possible problems of inconsistencies in decision-making and inequalities of access. The case of Spain is critically discussed, with special emphasis on the risk of favoring the application of micro formulae (such as risk-sharing arrangements) over macro formulae. Finally, a strategy is suggested, based on the recently approved Royal Decree-law 9/2011

22 November 2017 in Ciencias Económicas
Verified
Journal Article
Open access
PDF file
MSMarcia Das Merces Silva
Marcia Das Merces Silva
Laura Cabiedes-MiragayaLaura Cabiedes-Miragaya
Laura Cabiedes-Miragaya
Al inicio de los años 90, el Coeficiente de Gini situaba a Brasil entrelos países con peor distribución de la renta y de la riqueza. En 1988,la redemocratización del país culminó con una Constitución Federal que instituyó un sistema sanitario público nacional, de acceso universal. Este estudio ha analizado si el grado de equidad ha evolucionado desde la implantación del Sistema Único de Salud (SUS) en 1988, hasta el año 2000, pues la desigualdad se mantuvo en niveles altos durante este período. Para ello, se ha analizado el grado de equidad del SUS desde la financiación hasta los indicadores del gasto por región. Si bien se han observado marcadas desigualdades en salud entre las regiones, la comparación de los indicadores sanitarios indica que han disminuido las inequidades en el período analizado.